Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:IRTC News 9 January 2026 - 13 January 2026

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

New York, Jan 13, 2026, 14:56 (EST) — Regular session Shares of iRhythm Technologies (IRTC) fell 7.5% to $156.24 in Tuesday afternoon trading, following the company’s release of its 2026 sales and profitability goals alongside a plan for corporate restructuring. The timing is key. The update landed right in the middle of the J.P. Morgan Healthcare Conference in San Francisco, a week when medtech and biotech firms typically shape the year’s initial outlook. iRhythm is working hard to reassure investors it can sustain growth as it pushes toward profitability. The company hasn’t published its full 2025 results yet, leaving the
13 January 2026
·····
iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

New York, January 12, 2026, 16:13 EST — After-hours Shares of iRhythm Technologies Inc (IRTC.O) fell 5.6% to $169.30 in late Monday trading following a preliminary business update at the J.P. Morgan Healthcare Conference. The stock fluctuated between $157.34 and $179.82, with roughly 1.35 million shares changing hands. Timing is crucial. JPM week typically pushes companies to reveal their cards sooner, and the market has little patience for results that come off as just “fine” after a solid rally. iRhythm now expects 2025 revenue to top the high end of its previous guidance of $740 million, driven by record unit
12 January 2026
····
Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

New York, Jan 9, 2026, 15:54 EST — Regular session Shares of iRhythm Technologies (IRTC.O) fell 3.9% to $181.95 on Friday, after swinging between $190.16 and $179.61 in the session. The stock ended Thursday at $189.25. The drop left iRhythm behind a broader advance in U.S. equities, with S&P 500 and Nasdaq-tracking funds up about 0.8% and 1.1%, respectively. That gap matters because iRhythm trades like a growth stock — sensitive to rate moves and risk appetite — and those currents can swamp stock-specific news for stretches. A Labor Department report showed nonfarm payrolls — a broad count of jobs
9 January 2026
·····

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop